Cargando…
PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.
Expression of pS2, an oestrogen-regulated gene, has been associated with a good short-term prognosis and response to endocrine therapy. The aim of this study was to determine whether expression of mRNA for the pS2 gene in breast cancer could contribute useful information on disease behaviour and sur...
Autores principales: | Thompson, A. M., Elton, R. A., Hawkins, R. A., Chetty, U., Steel, C. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151284/ https://www.ncbi.nlm.nih.gov/pubmed/9472649 |
Ejemplares similares
-
pS2 is an independent factor of good prognosis in primary breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993) -
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1990) -
Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up.
por: Thompson, A. M., et al.
Publicado: (1998) -
Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?
por: Howell, Anthony
Publicado: (2010) -
The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.
por: Hug, V., et al.
Publicado: (1993)